6PZ5
Crystal Structure of HLA-B*2703 in complex with LRN, a self-peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-08-14 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.954 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 51.052, 82.510, 109.625 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.260 - 1.530 |
R-factor | 0.195 |
Rwork | 0.194 |
R-free | 0.22300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4g9d |
RMSD bond length | 0.010 |
RMSD bond angle | 1.010 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | BUSTER (2.10.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 46.280 | 1.560 |
High resolution limit [Å] | 1.530 | 1.530 |
Rpim | 0.039 | 0.339 |
Number of reflections | 82863 | 19314 |
<I/σ(I)> | 13 | |
Completeness [%] | 99.6 | |
Redundancy | 13 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.6 | 277 | 20-30% PEG 4K, 0.2M Na Acetate and 0.1M Na Citrate pH 5.6 |